Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 6 May 2027
- Last conf. stmt
- 22 April 2026
Covid Biopharma Limited
- Incorporated
- 23 April 2020 (6 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Owned by
- Peter Kadas
- Accounts type
- Dormant
- Region
- Greater London
- Address
- 1st Floor 40-44Newman StreetLondonW1T 1QD
Officers
Not loaded yet. See them on Companies House
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Peter Kadas
Individual · Notified 23 April 2020
Owns 25–50% of shares
Holds 25–50% of voting rights
British
Born February 1962 (64)
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £100
- Cash
- £0
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|
| Cash | £0 | £0 | USD 0 | USD 0 |
| Net Assets | £100 | £100 | USD 100 | USD 100 |
| Shareholder Funds | £100 | £100 | USD 100 | USD 100 |
Filings
Filing history not loaded yet. See it on Companies House
Some other companies at this address
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →